Form 4: Hims & Hers Health CFO Oluyemi Okupe Executes Stock Option Exercise and Sales Under 10b5-1 Plan

Oluyemi Okupe, CFO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on February 4, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On February 4, 2025, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., executed transactions involving the company's Class A Common Stock.
• Okupe exercised stock options to acquire 6,437 shares at a price of $5.01 per share.
• Concurrently, Okupe sold a total of 13,581 shares of Class A Common Stock at prices ranging from $38.7331 to $39.3048.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 31, 2024.
• Following these transactions, Okupe directly owns 112,933 shares of Class A Common Stock and holds options for 419,737 shares.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing simply reports transactions under a pre-existing trading plan. There's no indication of positive or negative outlook.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, which is a legal and transparent way for insiders to sell shares.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like the CFO, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The stock sales may have a slight negative impact on shareholders due to increased selling pressure, but the impact is likely minimal given the pre-planned nature of the transactions.

Key Dates